Effects of preemptive therapy with milrinone or amrinone on perioperative platelet function and haemostasis in patients undergoing coronary bypass grafting

Platelets

Volumn 14, Issue 5, 2003, Pages 277-282

  Kikura, Mutsuhito ^a   Sato, Shigehito ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMRINONE; MILRINONE;

ADULT; AGED; AORTA CLAMPING; ARTICLE; BLOOD AUTOTRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; FEMALE; HEART FUNCTION; HEART SURGERY; HEMATOLOGY; HEMOSTASIS; HUMAN; MALE; OXYGEN TRANSPORT; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THORAX DRAINAGE; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION;

EID: 0141455887     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1081/09537100310001594525     Document Type: Article

References (25)

1. Kikura M, Sato S. The efficacy of preemptive Milrinone or Amrinone therapy in patients undergoing coronary artery bypass grafting. Anesth Analg 2002; 94: 22-30, table of contents.
2. Hoffman T M, Wernovsky G, Atz AM, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003; 107: 996-1002.
3. Kinney E L, Ballard Jo, Carlin B, Zelis R. Amrinone-mediated thrombocytopenia. Scand J Haematol 1983; 31: 376-380.
4. Ansell J, Tiarks C, McCue J, Parrilla N, Benotti J R. Amrinone-induced thrombocytopenia. Arch Intern Med 1984; 144: 949-952.
5. Ross M P, Allen-Webb E M, Pappas J B, McGough E C. Amrinone-associated thrombocytopenia: pharmacokinetic analysis. Clin Pharmacol Ther 1993; 53: 661-667.
6. Fox J E, Reynolds C C, Johnson M M. Identification of glycoprotein Ib as one of the major proteins phosphorylated during exposure of intact platelets to agents that activate cAMP-dependent protein kinase. J Biol Chem 1987; 262: 12627-12631.
7. Wardell M R, Reynolds C C, Berndt M C, Wallace R W, Fox J E B. Platelet glycoprotein Ib beta is phosphorylated on serine 166 by cyclic AMP-dependent protein kinase. J Biol Chem 1989; 264: 15656-15661.
8. Hathaway D R, Adelstein R S. Human platelet myosin light chain kinase requires the calcium-binding protein calmodulin for activity. Proc Natl Acad Sci USA 1979; 76: 1653-1657.
9. O'Rourke F A, Halenda S P, Zavoico G B, Feinstein M B. Inositol 1,4,5-triphosphate releases Ca2+ from a Ca2+-transporting membrane vesicle fraction derived from human platelets. J Biol Chem 1985; 260: 956-962.
10. Brass L F, Joseph S K. A role for inositol triphosphate in intracellular Ca2+ mobilization and granule secretion in platelets. J Biol Chem 1985; 260: 15172-15179.
11. Kaser-Glanzmann R, Jakabova M, George J N, Luscher E F. Stimulation of calcium uptake in platelet membrane vesicles by adenosine 3′,5′ -cyclic monophosphate and protein kinase. Biochim Biophys Acta 1977; 466: 429-440.
12. Sorensen G K, Ramamoorthy C, Lynn A M, French J, Stevenson J G. Hemodynamic effects of amrinone in children after Fontan surgery. Anesth Analg 1996; 82: 241-246.
13. Ramamoorthy C, Anderson G D, Williams G D, Lynn A M. Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery. Anesth Analg 1998; 86: 283-9.
14. Kikura M, Lee M K, Safon R A, Bailey J M, Levy J H. Effects of milrinone on platelets in patients undergoing cardiac surgery. Anesth Analg 1995; 81: 44-48.
15. Harker L. Bleeding after cardiopulmonary bypass. N Engl J Med 1986; 314: 1446-1448.
16. Born G V R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-929.
17. Cardinal D C, Flower R J. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980; 3: 135-158.
18. Chignard M, Selak M A, Smith J B. Direct evidence for the existence of a neutrophil-derived platelet activator (neutrophilin). Proc Natl Acad Sci USA 1986; 83: 8609-8613.
19. Santos M T, Valles J, Marcus A J, et al. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest 1991; 87: 571-580.
20. Riess H, Braun G, Brehm G, Hiller E. Critical evaluation of platelet aggregation in whole human blood. Am J Clin Pathol 1986; 85: 50-56.
21. Ingerman-Wojenski C, Smith J B, Silver M J. Evaluation of electrical aggregometry: comparison with optical aggregometry, secretion of ATP, and accumulation of radiolabeled platelets. J Lab Clin Med 1983; 101: 44-52.
22. Mangano D T. Biventricular function after myocardial revascularization in humans: Deterioration and recovery patterns during the first 24 hours. Anesthesiology 1985; 62: 571-577.
23. Breisblatt W M, Stein K L, Wolfe C J, et al. Acute myocardial dysfunction and recovery: A common occurrence after coronary bypass surgery. J Am Coll Cardiol 1990; 15: 1261-1269.
24. Baim D S, McDowell A V, Cherniles J, et al. Evaluation of a new bipyridine inotropic agent-milrinone-in patients with severe congestive heart failure. N Engl J Med 1983; 309: 748-56.
25. Mehra M R, Ventura H O, Kapoor C, Stapleton D D, Zimmerman D, Smart F W. Safety and clinical utility of long-term intravenous milrinone in advanced heart failure. Am J Cardiol 1997; 80: 61-4.